Recent Updates
Recently added Catalysts
MDXG Positive Sentiment

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

Key Takeaway: MiMedx Group, Inc. will announce its second quarter 2026 operating and financial results on July 29, 2026. The results will be shared during a conference call at 4:30 p.m. ET, accessible to both U.S. and international investors. A replay of the call will be available for 30 days on their website.
Price reaction · baseline $4.3 (2026-07-17 close) · hit pre-market · clean, no other MDXG news in the window
day 0 close · peak
+0.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX is reporting its financial results, indicating transparency.
  • The company is actively engaging with investors through a conference call.
  • MIMEDX continues to innovate in the healthcare sector.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles

Full Press Release Details

MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, July 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast:Click hereU.S. Investors: 877-407-6184International Investors: 201-389-0877Conference ID: 13761338
A replay of the webcast will be available for approximately 30 days on the Company’s website atwww.mimedx.comfollowing the conclusion of the event.
About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visitwww.mimedx.com.

Contact:Matt NotarianniInvestor Relations470-304-7291mnotarianni@mimedx.com

Frequently Asked Questions

When will MIMEDX report its Q2 2026 results?

MIMEDX will report its Q2 2026 results on July 29, 2026.

What time is the MIMEDX conference call?

The conference call will begin at 4:30 p.m. Eastern Time.

How can I access the MIMEDX conference call?

The call can be accessed via a webcast or by calling the provided numbers.

Will there be a replay of the conference call?

Yes, a replay will be available for approximately 30 days on their website.

Last updated: Jul 20, 2026